83 related articles for article (PubMed ID: 1365432)
1. Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers.
Di Chiara G; Tanda GL; Frau R; Carboni E
Neurochem Int; 1992 Mar; 20 Suppl():231S-235S. PubMed ID: 1365432
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.
Carboni E; Tanda GL; Frau R; Di Chiara G
J Neurochem; 1990 Sep; 55(3):1067-70. PubMed ID: 2117046
[TBL] [Abstract][Full Text] [Related]
3. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
4. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
Devoto P; Flore G; Pira L; Diana M; Gessa GL
Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
[TBL] [Abstract][Full Text] [Related]
5. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
Valentini V; Cacciapaglia F; Frau R; Di Chiara G
J Neurochem; 2006 Jul; 98(1):113-21. PubMed ID: 16805801
[TBL] [Abstract][Full Text] [Related]
6. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Longu G; Pira L; Gessa GL
Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
[TBL] [Abstract][Full Text] [Related]
7. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine.
Tanda G; Pontieri FE; Frau R; Di Chiara G
Eur J Neurosci; 1997 Oct; 9(10):2077-85. PubMed ID: 9421168
[TBL] [Abstract][Full Text] [Related]
8. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.
Devoto P; Flore G; Saba P; Fà M; Gessa GL
J Neurochem; 2005 Jan; 92(2):368-74. PubMed ID: 15663484
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
Bongiovanni R; Newbould E; Jaskiw GE
Brain Res; 2008 Jan; 1190():39-48. PubMed ID: 18082673
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
Pehek EA
J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
[TBL] [Abstract][Full Text] [Related]
13. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus.
Devoto P; Flore G; Saba P; Fà M; Gessa GL
BMC Neurosci; 2005 May; 6():31. PubMed ID: 15865626
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine administration does not affect desipramine-induced dopamine levels as measured in vivo in prefrontal cortex.
Bongiovanni R; Kirkbride B; Walmire P; Jaskiw GE
Brain Res; 2005 Aug; 1054(2):203-6. PubMed ID: 16083866
[TBL] [Abstract][Full Text] [Related]
15. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.
Linnér L; Endersz H; Ohman D; Bengtsson F; Schalling M; Svensson TH
J Pharmacol Exp Ther; 2001 May; 297(2):540-6. PubMed ID: 11303041
[TBL] [Abstract][Full Text] [Related]
16. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
17. Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium.
Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
Eur J Pharmacol; 2005 Jun; 516(3):219-26. PubMed ID: 15963494
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
19. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
Stephans SE; Yamamoto BK
Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
